This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Salazar-Paramo, M. Articles by Anglés-Cano, E. Search for Related Content PubMed PubMed Citation Articles by Salazar-Paramo, M. Articles by Anglés-Cano, E. Social Bookmarking                         What's this?

Review : Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis

The University of Guadalajara and Department of Immunology and Rheumatology, Hospital General de Occidente, Guadalajara, Jalisco, Mexico

Ignacio Garcia de la Torre

The University of Guadalajara and Department of Immunology and Rheumatology, Hospital General de Occidente, Guadalajara, Jalisco, Mexico

Marvin J Fritzler

Department of Medicine and Medical Biochemistry, The University of Calgary, AB, Canada

Stéphane Loyau

INSERM U.143, Hôpital de Bicêtre, Paris, France

Eduardo Anglés-Cano

INSERM U.143, Hôpital de Bicêtre, Paris, France

Fibrinolysis triggered by t-PA bound to fibrin is one of the main antithrombotic mecha nisms. Defects in the fibrinolytic system - decreased tissue-type plasminogen activator (t- PA) activity and elevated levels of plasminogen activator inhibitor (PAI-1), in patients with SLE have been associated with an increased tendency to thrombosis. In the present study, 43 patients with SLE fulfilling the ACR criteria for the disease, were studied for the presence of autoantibodies to fibrin-bound t-PA, i.e. the physiological active form of this plasmin ogen activator. A solution of 200IU/ml of t-PA was incubated with solid-phase fibrin pre pared as previously described (Anal Biochem 1986; 153: 201-210). Sera diluted 1 : 50 were incubated with fibrin-bound t-PA, the plates were then washed, and bound immuno globulins were detected using a polyvalent peroxidase-labeled goat anti-human Ig. Plates coated with fibrin alone were used as controls. Sera were considered positive when A490/ 630 obtained with normal human sera in two independent test was greater than the mean plus 2 SD. Eleven of 43 (26%) SLE sera demonstrated antibody reactivity against fibrin- bound t-PA. Within the anti-t-PA positive group there was a higher proportion of SLE patients with severe Raynaud's phenomenon and thrombotic events when compared to the anti-t-PA negative group: 36% vs 6% and 18% vs 6%, respectively. These results suggest that autoantibodies to fibrin-bound t-PA could play a role in the pathogenesis of vascular disease in some SLE patients.

Key Words: autoantibodies • tissue-type plasminogen activator • thrombosis • Raynaud's • sys temic lupus erythematosus

Lupus, Vol. 5, No. 4, 275-278 (1996)
DOI: 10.1177/096120339600500406


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. A. Palafox-Sanchez, M. Vazquez-Del Mercado, G. Orozco-Barocio, I. Garcia-De la Torre, N. Torres-Carrillo, N. M. Torres-Carrillo, B. Illades-Aguiar, and J. F. Munoz-Valle A Functional Ser413/Ser413 PAI-2 Polymorphism Is Associated With Susceptibility and Damage Index Score in Systemic Lupus Erythematosus Clinical and Applied Thrombosis/Hemostasis, April 1, 2009; 15(2): 233 - 238. [Abstract] [PDF]

				M. Cugno, M. Cabibbe, M. Galli, P. L. Meroni, S. Caccia, R. Russo, B. Bottasso, and P. M. Mannucci Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients Blood, March 15, 2004; 103(6): 2121 - 2126. [Abstract] [Full Text] [PDF]

				P. De Pablo, A. Ramirez, E. Cortina, A. D. l. Pena, J. Zamora, R. Izaguirre, and M.-C. Amigo Increased Fibrin Polymerization Rate in Patients with Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 221 - 225. [Abstract] [PDF]

				J H Morse Genetic studies of pulmonary arterial hypertension Lupus, March 1, 2003; 12(3): 209 - 212. [Abstract] [PDF]

				W. Lu, M. Bhasin, and S. E. Tsirka Involvement of Tissue Plasminogen Activator in Onset and Effector Phases of Experimental Allergic Encephalomyelitis J. Neurosci., December 15, 2002; 22(24): 10781 - 10789. [Abstract] [Full Text] [PDF]

				M Puurunen, T Palosuo, R Lassila, M Anttila, and O Vaarala Immunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model Lupus, February 1, 2001; 10(2): 108 - 115. [Abstract] [PDF]

				C A von Muhlen, E K. Chan, E Angles-Cano, M J Mamula, I Garcia-De La Torre, and M J Fritzler Advances in autoantibodies in SLE Lupus, October 1, 1998; 7(8): 507 - 514. [PDF]